e-learning
resources
Munich 2006
Monday 04.09.2006
New methods to diagnose tuberculosis infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis?
J. P. Janssens, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat (Geneva, Switzerland)
Source:
Annual Congress 2006 - New methods to diagnose tuberculosis infection
Session:
New methods to diagnose tuberculosis infection
Session type:
Oral Presentation
Number:
2177
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. P. Janssens, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat (Geneva, Switzerland). Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis?. Eur Respir J 2006; 28: Suppl. 50, 2177
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
How patients cope with exacerbations in primary care: the COPD health study
Source: Annual Congress 2006 - Exacerbation of COPD
Year: 2006
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
The efficiency of the treatment of the patients with culture-positive pulmonary tuberculosis (CPPTB) in Gdannsk, Poland in 1995 and 2000
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005
Determinants of success
Source: Eur Respir J 2011; 38: 1215-1218
Year: 2011
Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Incidence and etiology of adult asthma in general population
Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma
Year: 2005
Spirometry screening in the community: is this an effective way of diagnosing early COPD?
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
TB and COVID-19 – a dangerous new combination?
Source: ERS webinar 2021: TB and COVID-19 – a dangerous new combination?
Year: 2021
The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS)
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Pulmonary tuberculosis
Source: Respipedia Article
Year: 2018
Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept